Novo Nordisk is the world’s leading producer of insulin and insulin delivery devices.
GRO has been collaborating with Novo Nordisk since 2012.
Working closely with design management and in-house engineers, we have helped to design pen-type insulin delivery devices for both durable and disposable categories, as well as exploring more upstream conceptual projects for new types of drug delivery devices.
User at the centre of the design process.
Designing insulin pens is a serious business: they can be life-saving devices. Innovation in product design is key to making meaningful advances in user experience and to being successful in this highly competitive market.
At GRO, we put the user at the centre of our design process and decision making, to make sure they have the best possible experience at every touch point. Through an iterative process of design development and user testing, we continuously adjust, improve and refine the solutions we propose.
